Deltex Medical wins NICE recommendation for CardioQ-ODM

Medical Company Product News

Deltex Medical has earned a recommendation from the National Institute for Health and Clinical Excellence (NICE) for its CardioQ-ODM oesophageal Doppler monitor.

The UK regulator has issued guidance that endorses the technology for use in major and high-risk surgery, with estimates suggesting that its widespread use could save the NHS 880 million pounds a year.

Deltex's device uses a disposable ultrasound probe placed in the oesophagus to measure blood flow in the central circulation, allowing clinicians to deliver fluid guided management in patient recovery.

This facilitates the post-surgical healing process and helps patients to leave hospital earlier and in a better condition, which also allows medical facilities to save money.

Ewan Phillips, Deltex's chief executive, said: "NICE's final guidance is a resounding endorsement for the CardioQ-ODM at a time when the NHS is charged with delivering 20 billion pounds of efficiency savings over the next three years."

The CardioQ-ODM was researched and designed at the firm's UK base and has been used to benefit more than 400,000 patients to date.

See all the latest jobs in Medical Devices
Return to news

Tags